245

News

Danish company to supply US with monkeypox vaccine

Amy Thorpe
July 12th, 2022


This article is more than 2 years old.

Bavarian Nordic will deliver 4.4 million units by the end of 2023.

Fourth vaccine jab from November 15 (photo: Mirko Sajkov, Pixabay)

Following a contract signed by the US government, the Danish company Bavarian Nordic is set to supply the US with a total of 4.4 million monkeypox vaccines.

This number represents the composite of several orders placed by the US Biomedical Advanced Research and Development Authority – the most recent one being for 2.5 million liquid-frozen doses.

Favourable approval for Jynneos
The vaccine, named Jynneos, protects against non-replicating smallpox, a disease so similar to monkeypox that it can be fought using the same technology. Jynneos is the only monkeypox vaccine to have been approved by the US Food and Drug Administration so far.

“The monkeypox outbreak continues to develop at an unprecedented rate, and we applaud the US government’s decision to prioritise the supply of our vaccine to enable broader access for those at risk of infections,” said Paul Chaplin, the president and CEO of Bavarian Nordic.

The newest order of 2.5 million Jynneos doses will be delivered over the course of 2022 and 2023.

Rising case count
Nearly 10,000 monkeypox cases have been detected around the world amid the ongoing outbreak, with approximately 900 of those cases being in the US, according to the Center for Disease Control.

The World Health Organization has referred to monkeypox as an “evolving health threat” that needs a collective response.

In accordance, Bavairan Nordic has also entered into vaccine supply agreements with countries outside the US, including European Union member states and Canada.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”